Attenuated bacterial strains allow the administration of recombinant vaccin
es via the mucosal surfaces. Whereas attenuated bacteria are generally engi
neered to express heterologous antigens, a novel approach employs intracell
ular bacteria for the delivery of eukaryotic antigen expression vectors (so
-called DNA vaccines). This strategy allows a direct delivery of DNA to pro
fessional antigen-presenting cells (APC), such as macrophages and dendritic
cells (DC), through bacterial infection. The bacteria used for DNA vaccine
delivery either enter the host cell cytosol after phagocytosis by the APC,
for example, Shigella and Listeria, or they remain in the phagosomal compa
rtment, such as Salmonella. Both intracellular localizations of the bacteri
al carriers seem to be suitable for successful delivery of DNA vaccine vect
ors.